Posts

Showing posts from April, 2020

Pagpapalawig ng deadline para sa 2020 DOST IPA at NSTW Awards

Ipinapaalam ng National Academy of Science and Technology Philippines (NAST PHL) na ang pagpasa ng kanilang mga lahok o entry para sa 2020 Department of Science and Technology Intellectual Property Awards (DOST IPA) at sa 2020 Department of Science and Technology National Science and Technology Week (DOST NSTW) Awards ay pinalawig takdang panahon ng pagsusumite hanggang sa ika-21 ng Mayo 2020. Maaaring i-download ang mga nomination form para sa mga nabanggit na Awards sa http://nast.ph/index.php/about-nast/functions/recognition .

ADVISORY FOR ALL DOST SETUP BENEFICIARIES

The Department of Science and Technology (DOST) is extending the moratorium of refund payment for the beneficiaries of the Small Enterprise Technology Upgrading Program (SETUP) given the extension of the Enhanced Community Quarantine (ECQ). The extension will be for additional three (3) months from May-July 2020. This extension is our way of helping our micro, small, and medium enterprises (MSMEs) for the losses they have incurred, and continue to incur, during this pandemic health crisis.  SETUP is a flagship program and nationwide strategy of the DOST that aims to assist MSMEs through adoption of technology innovations to improve their operations and boost their productivity and competitiveness.  #WeHealAsOne  #dostPH   #ScienceForThePeople

VCO CLINICAL STUDIES BY DOST, UP-PGH, AND PCA

Image
This research of the Department of Science and Technology (DOST) on virgin coconut oil (VCO) is planned to have two arms: one hospital-based and one community-based.  For the hospital based, the study entitled, “Virgin Coconut Oil and Omega-3a Adjunctive Therapy for Hospitalized Patients with COVID 19” will be conducted at the Philippine General Hospital (UP-PGH) and will be led by Dr. Marissa Alejandria. The VCO will serve as a supplement to the daily treatment regimen of the COVID-19 positive patients. The study aims to assess the possible benefits of VCO if given to patients with moderate to severe COVID-19 in addition to the drugs being assessed in the clinical trials. This arm may possibly run for a minimum of one month or until the minimum number of patients have been achieved. This is in cooperation with the DOST and the UP-PGH Clinical COVID-19 Research Group and the Metro Manila Health Research and Development Consortium of the Philippine Council for Health Research a...